【结 构 式】 |
【分子编号】42908 【品名】N-[[(2S)-1-ethylpyrrolidinyl]methyl]-6-hydroxy-2,3-dimethoxybenzamide 【CA登记号】 |
【 分 子 式 】C16H24N2O4 【 分 子 量 】308.37764 【元素组成】C 62.32% H 7.84% N 9.08% O 20.75% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(III)The lithiation of N-(1-ethylpyrroidin-2(S)-ylmethyl)-2,3-dimethoxybenzamide (I) with n-BuLi gives the dilithium salt (II), which by treatment with butyl borate, H2O2 and ammonium chloride yields N-(1-ethylpyrrolidin-2(S)-ylmethyl)-6-hydroxy-2,3-dimethoxybenzamide (III). Finally, this compound is iodinated with 123INa and chloramine T.
【1】 Hogberg, M.; Novel substituted salicylamides and benzamides as selective dopamine D2-receptor antagonists. Drugs Fut 1991, 16, 4, 333. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 42899 | N-[[(2S)-1-ethylpyrrolidinyl]methyl]-2,3-dimethoxybenzamide | C16H24N2O3 | 详情 | 详情 | |
(II) | 42900 | lithium [2-[([[(2S)-1-ethylpyrrolidinyl]methyl]imino)(oxido)methyl]-3,4-dimethoxyphenyl]lithium | C16H22Li2N2O3 | 详情 | 详情 | |
(III) | 42908 | N-[[(2S)-1-ethylpyrrolidinyl]methyl]-6-hydroxy-2,3-dimethoxybenzamide | C16H24N2O4 | 详情 | 详情 |
Extended Information